The sales of modulators of the genital system and sex hormones in Italy are projected to remain largely stable from 2024 to 2028 at 1.6 to 1.7 USD per capita. In 2023, this figure was also comparable, demonstrating negligible growth or decline in per capita sales over the recent years. The year-on-year variation reflects a stable market with no significant fluctuations, while the CAGR over the next five years indicates a lack of growth trend in this market segment.

Future trends to watch for:

Potential impacts of regulatory changes on the pricing and availability of these drugs.
Shifts in consumer preferences towards alternative treatments or lifestyle changes affecting demand.
Technological advancements or new product launches that may influence market dynamics.